Hostname: page-component-8448b6f56d-mp689 Total loading time: 0 Render date: 2024-04-20T04:34:54.155Z Has data issue: false hasContentIssue false
  • English
  • Français

Are There Regional Variations in the Diagnosis, Surveillance, and Control of Methicillin-Resistant Staphylococcus aureus?

Published online by Cambridge University Press:  02 January 2015

Hervé M. Richet ,
Mohamed Benbachir ,
Derek F. J. Brown ,
Helen Giamarellou ,
Ian Gould ,
Marija Gubina ,
Piotr Heczko ,
Smilja Kalenic ,
Marina Pana  and
Didier Pittet
...Show all authors
Hervé M. Richet*
Affiliation:
Investigation and Prevention Branch, Hospital Infections Program, Centers for Disease Control and Prevention, Atlanta, Georgia
Mohamed Benbachir
Affiliation:
Laboratoire de Microbiologie, Centre Hospitalier Ibn Rochd, Casablanca, Maroc
Derek F. J. Brown
Affiliation:
Clinical Microbiology and Public Health Laboratory, Addenbrooke's Hospital, Cambridge, United Kingdom
Helen Giamarellou
Affiliation:
4th Department of Internal Medicine, Sismanoglio General Hospital, Maroussi Attikis, Greece
Ian Gould
Affiliation:
Clinical Microbiology, Aberdeen Royal Hospitals, NHS Trust, Aberdeen, Scotland, United Kingdom
Marija Gubina
Affiliation:
Institute of Microbiology and Immunology, Medical Faculty, University of Ljubljana, Ljubljana, Slovenia
Piotr Heczko
Affiliation:
Microbiology Department, Jagiellonian University Medical School, Krakow, Poland
Smilja Kalenic
Affiliation:
Department of Clinical and Molecular Microbiology, Zagreb University School of Medicine, Zagreb, Croatia
Marina Pana
Affiliation:
Streptococcus National Reference Center, Institutul Cantacuzino, Bucarest, Romania
Didier Pittet
Affiliation:
Unité de Prévention et de Contrôle de l'Infection, Hôpitaux Universitaires de Genève, Genève, Suisse
Saida Ben Redjeb
Affiliation:
Laboratoire de Bactériologie, Hôpital Charles Nicolle, Tunis, Tunisie
Jiri Schindler
Affiliation:
Department of Medical Microbiology, 3rd Faculty of Medicine, Charles University, Prague, Czech Republic
Carlos Starling
Affiliation:
Fetido Rocho, Vera Cruz and São Francisco Hospitals, Belo Horizonte, Brazil
Marc J. Struelens
Affiliation:
Department of Microbiology, Université Libre de Bruxelles, Hôpital Erasme, Bruxelles, Belgique
Wolfgang Witte
Affiliation:
Robert-Koch Institut, Bunderinstitüt für Infektionskrankheiten, Wernigerode, Germany
William R. Jarvis
Affiliation:
Investigation and Prevention Branch, Hospital Infections Program, Centers for Disease Control and Prevention, Atlanta, Georgia
*
Laboratoire de Bactériologie-Virologie-Hygiène Hospitalière, Institut de Biologie des Hôpitaux de Nantes, 9, quai Moncousu, BP 1005, 44093 Nantes cedex 01, France
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective:

To assess the way healthcare facilities (HCFs) diagnose, survey, and control methicillin-resistant Staphylococcus aureus (MRSA).

Design:

Questionnaire.

Setting:

Ninety HCFs in 30 countries.

Results:

Evaluation of susceptibility testing methods showed that 8 laboratories (9%) used oxacillin disks with antimicrobial content different from the one recommended, 12 (13%) did not determine MRSA susceptibility to vancomycin, and 4 (4.5%) reported instances of isolation of vancomycin-resistant S. aureus but neither confirmed this resistance nor alerted public health authorities. A MRSA control program was reported by 55 (61.1%) of the HCFs. The following isolation precautions were routinely used: hospitalization in a private room (34.4%), wearing of gloves (62.2%), wearing of gowns (44.4%), hand washing by healthcare workers (53.3%), use of an isolation sign on the patient's door (43%), or all four. When the characteristics of HCFs with low incidence rates (< 0.4 per 1,000 patient-days) were compared with those of HCFs with high incidence rates (P = 0.4 per 1,000 patient-days), having a higher mean number of beds per infection control nurse was the only factor significantly associated with HCFs with high incidence rates (834 vs 318 beds; P = .02).

Conclusion:

Our results emphasize the urgent need to strengthen the microbiologic and epidemiologic capacities of HCFs worldwide to prevent MRSA transmission and to prepare them to address the possible emergence of vancomycin-resistant S. aureus.

Type
Orginal Articles
Information
Infection Control & Hospital Epidemiology , Volume 24 , Issue 5 , May 2003 , pp. 334 - 341
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2003

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Go, ES, Urban, C, Burns, J, et al.Clinical and molecular epidemiology of Acinetobacter infections sensitive only to polymyxin B and sulbactam. Lancet 1994;344:1329–1332.CrossRefGoogle ScholarPubMed
2.Richard, P, Le Floch, R, Chamoux, C, Pannier, M, Espaze, E, Richet, H. Pseudomonas aeruginosa outbreak in a burn unit: role of antimicrobials in the emergence of multiply resistant strains. J Infect Dis 1994;170:377–383.CrossRefGoogle Scholar
3.French, GL, Shannon, KP, Simmons, N. Hospital outbreak of Klebsiella pneumoniae resistant to broad-spectrum cephalosporins and β-lactam-β-lactamase inhibitor combinations by hyperproduction of SHV5 β-lactamase. J Clin Microbiol 1996;34:358–363.CrossRefGoogle ScholarPubMed
4.Neuwirth, C, Siebor, E, Pechinot, A, Kazmierczak, A. Outbreak of TEM-24-producing Enterobacter aerogenes in an intensive care unit and dissemination of the extended spectrum β-lactamase to other members of the family enterobacteriaceae. J Clin Microbiol 1996;34:76–79.CrossRefGoogle Scholar
5.Morosini, MI, Canton, R, Martinez-Beltran, J, et al.New extended-spectrum TEM-type β-lactamase from Salmonella enterica isolated in a nosocomial outbreak. Antimicrob Agents Chemother 1995;39:458–461.CrossRefGoogle Scholar
6.Pagani, L, Luzzaro, F, Ronza, P, et al.Outbreak of extended spectrum β-lactamase producing Serratia marcescens in an intensive care unit. FEMS Immunol Med Microbiol 1994;10:39–46.Google Scholar
7.Johnson, DR, Love-Dixon, MA, Brown, WJ, Levine, DP, Downes, FP, Hall, WN. Delayed detection of an increase in resistant Acinetobacter bau-mannii at a Detroit hospital. Infect Control Hosp Epidemiol 1992;13:394–398.CrossRefGoogle Scholar
8.Meyer, KS, Urban, C, Eagan, JA, Berger, BJ, Rahal, JJ. Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins. Ann Intern Med 1993;119:353–358.CrossRefGoogle ScholarPubMed
9.Trick, WE, Kuehnert, MJ, Quirk, SB, et al.Regional dissemination of vancomycin-resistant enterococci resulting from interfacility transfer of colonized patients. J Infect Dis 1999;180:391–396.CrossRefGoogle ScholarPubMed
10.Austin, DJ, Anderson, RM. Transmission dynamics of epidemic methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci in England and Wales. J Infect Dis 1999;179:883–891.CrossRefGoogle ScholarPubMed
11.Kim, WJ, Weinstein, RA, Hayden, MJ. The changing molecular epidemiology and establishment of endemicity of vancomycin resistance in enterococci at one hospital over a 6-year period. J Infect Dis 1999;179:163–171.CrossRefGoogle Scholar
12.Michel, M, Gutmann, L. Methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci: therapeutic realities and possibilities. Lancet 1997;349:1901–1906.CrossRefGoogle ScholarPubMed
13.Smith, TL, Pearson, ML, Wilcox, KR, et al.Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-intermediate Staphylococcus aureus working group. N Engl J Med 1999;340:493–501.CrossRefGoogle ScholarPubMed
14.Barber, M. Methicillin-resistant staphylococci. J Clin Pathol 1961;14:385–393.CrossRefGoogle ScholarPubMed
15.Chabbert, YA, Baudens, JG. Souches de staphylocoques resistants naturellement a la meticilline et a la 5 methyl-3-phenyl-4-iso-oxazyl penicilline (P12). Annales de l'Institut Pasteur (Paris) 1962:103:222–230.Google Scholar
16.Richet, H, Wiesel, M, Le Gallou, F, Andre-Richet, B, Espaze, E. Methicillin-resistant Staphylococcus aureus control in hospitals: the French experience. Infect Control Hosp Epidemiol 1996;17:509–511.CrossRefGoogle ScholarPubMed
17.Farrington, M, Redpath, C, Trundle, C, Coomber, S, Brown, NM. Winning the battle but losing the war: methicillin-resistant Staphylococcus aureus (MRSA) infections at a teaching hospital. QJM 1998;91:539–548.CrossRefGoogle ScholarPubMed
18.Hiramatsu, K, Aritaka, N, Hanaki, H, et al.Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet 1997;350:1670–1673.CrossRefGoogle ScholarPubMed
19.Ploy, MC, Grelaud, C, Martin, C, de Lumley, L, Denis, F. First clinical isolate of vancomycin-intermediate Staphylococcus aureus in a French Hospital. Lancet 1998;351:1212.CrossRefGoogle Scholar
20.Maguire, GRArthur, AD, Boustead, PJ, Dwyer, B, Currie, BJ. Clinical experience and outcomes of community-acquired and nosocomial methicillin-resistant Staphylococcus aureus in a northern Australian hospital. J Hosp Infect 1998;38:273–281.CrossRefGoogle Scholar
21.Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus: Minnesota and North Dakota, 1997-1999. MMWR 1999;48:707–710.Google Scholar
22.L'Heriteau, F, Lucet, JC, Scanvic, A, Bouvet, E. Community-acquired methicillin-resistant Staphylococcus aureus and familial transmission. JAMA 1999;282:1038–1039.CrossRefGoogle ScholarPubMed
23.Shahin, R, Johnson, IL, Jamieson, F, McGeer, A, Tolkin, J, Ford-Jones, EL. Methicillin-resistant Staphylococcus aureus carriage in a child care center following a case of disease: Toronto Child Care Study Group. Arch Pediatr Adolesc Med 1999;153:864–868.CrossRefGoogle Scholar
24.Chaix, C, Durand-Zaleski, I, Alberti, C, Brun-Buisson, C.Control of endemic methicillin-resistant Staphylococcus aureus: a cost-benefit analysis in an intensive care unit. JAMA 1999;282:1745–1751.CrossRefGoogle Scholar
25.Schentag, JJ, Hyatt, JM, Carr, JR, et al.Genesis of methicillin-resistant Staphylococcus aureus (MRSA): how treatment of MRSA infections has selected for vancomycin-resistant Enterococcus faecium and the importance of antibiotic management and infection control. Clin Infect Dis 1998;26:1204–1214.CrossRefGoogle ScholarPubMed
26.Jernigan, JA, Titus, MG, Groschel, DH, Getchell-White, S, Farr, BM. Effectiveness of contact isolation during a hospital outbreak of methicillin-resistant Staphylococcus aureus. Am J Epidemiol 1996;143:496–504.CrossRefGoogle ScholarPubMed
27.Barrett, SP, Mummery, RV, Chattopadhyay, B. Trying to control MRSA causes more problems than it solves. J Hosp Infect 1998;39:85–93.CrossRefGoogle ScholarPubMed
28.Fazal, BATelzak, EE, Blum, S, Turett, GS, Ptersen-Fitzpatrick, FE, Lorian, V. Trends in the prevalence of methicillin-resistant Staphylococcus aureus associated with discontinuation of an isolation policy. Infect Control Hosp Epidemiol 1996;17:372–374.CrossRefGoogle ScholarPubMed
29.Harbarth, S, Martin, Y, Rohner, P, Henry, N, Auckenthaler, R, Pittet, D. Effect of delayed infection control measures on a hospital outbreak of methicillin-resistant Staphylococcus aureus. J Hosp Infect 2000;46:43–49.CrossRefGoogle ScholarPubMed
30.Garner, IS. Guideline for isolation precautions in hospitals: the Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 1996;17:53–80.CrossRefGoogle ScholarPubMed